Patents
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
03/2004
03/23/2004US6710027 Bacillus thuringiensis toxins and genes for controlling coleopteran pests
03/23/2004US6709867 Transgenic turfgrasses which signal exposure to chemicals and stress conditions
03/23/2004US6709865 Isolated nucleic acid molecule comprising specified nucleotide sequence which encodes polypeptide having lipoxygenase activity; modulating development and defense response in plants
03/23/2004US6709863 Nucleotide sequence for use as diagnostic tools in genetic engineering
03/23/2004US6709861 Allow insert sequences that are deleterious to a host cell to be successfully cloned
03/23/2004US6709860 Construct comprising adipose-specific promoter operably linked to nucleotide sequence encoding polypeptide comprising specified amino acid sequence
03/23/2004US6709859 Chromosomal DNA Fragments Encoding Enzymes for Encoding B-Lactam Biosynthesis Enzymes, and Vector and Transformants for Their Expression
03/23/2004US6709858 Hyperthermic inducible expression vectors for gene therapy and methods of use thereof
03/23/2004US6709854 Method capable of increasing competency of bacterial cell transformation
03/23/2004US6709852 Isolated e. coli lacking endogenous plasmids and having a growth rate that is at least 5% greater than the growth rate of e. coli mm294, dh5 alpha and dh10b
03/23/2004US6709851 Stabilization of helicobacter urease
03/23/2004US6709850 Isolated human enzyme proteins, nucleic acid molecules encoding human enzyme proteins, and uses thereof
03/23/2004US6709848 Methods for isolating polyhydroxyalkanoates from plants
03/23/2004US6709844 Bacterial plasmid- based shuttle vectors free of linear plasmid-derived dna contaminants, and particularly such vectors as might be used in dna vaccination and gene therapy
03/23/2004US6709842 DNA encoding a growth factor specific for epithelial cells
03/23/2004US6709841 Generating preferential polypeptide; obtain cell, transform with vector coding preferential polypeptide, recover polypeptide
03/23/2004US6709839 SYK-UBP proteins, compositions and methods of use
03/23/2004US6709838 Nucleic acid encoding patched-2
03/23/2004US6709837 Reagent for studies relating to the differentiation, growth and survival of animal cells, and may also be useful as a drug
03/23/2004US6709834 Hybrid nucleotide sequence
03/23/2004US6709833 Antibody for use as tool in immunoassay
03/23/2004US6709831 DNA encoding mammalian neuropeptide FF (NPFF) receptors and uses thereof
03/23/2004US6709830 Methods for modulating the activation of a lymphocyte expressed G protein coupled receptor involved in cell proliferation, autoimmunity and inflammation
03/23/2004US6709827 Detecting mutation in nucleotide sequences; obtain nucleotide sequences, join to oligomers, transform cells, detect mutations
03/23/2004US6709821 Polypeptides having a functional domain of interest and methods of identifying and using same
03/23/2004US6709815 Target-dependent reactions using structure-bridging oligonucleotides
03/23/2004US6709814 Dimerization peptides that self-associate
03/23/2004US6709812 Method for typing and detecting HBV
03/23/2004US6709661 Leishmania antigens for use in the therapy and diagnosis of leishmaniasis
03/23/2004US6709660 Meningococcal antigens
03/23/2004US6709657 Includes immunogenic fragment of at least 15 amino acids matching aligned contiguous segment of sequence 2
03/23/2004US6709656 Polyclonal and/or monoclonal immunoglobulin immunization
03/23/2004US6709654 Treatment of psoriasis using anti-B7.1 (CD80) antibodies
03/23/2004CA2336207C Ecdysone receptors and methods for their use
03/23/2004CA2245576C Process for preparing purified nucleic acid and the use thereof
03/23/2004CA2236670C Strand displacement amplification of rna targets
03/23/2004CA1341452C Method of inducing lysine overproduction in plants
03/19/2004CA2438778A1 Fusion proteins comprising hiv-nef and lngfr and methods of using same
03/19/2004CA2400254A1 Compositions and methods for treating heart disease
03/18/2004WO2004023146A2 Methods for assaying protein-protein interactions
03/18/2004WO2004023138A1 Method of screening remedy for aids
03/18/2004WO2004023137A2 Method for screening for mutant virus movement proteins (mp)
03/18/2004WO2004023117A1 Image processing method for biochemical examination
03/18/2004WO2004023092A2 Genetic analysis and authentication
03/18/2004WO2004022786A1 Method of analyzing protein using fluorescent resonance energy transfer
03/18/2004WO2004022782A2 Compositions and methods for tissue specific or inducible inhibition of gene expression
03/18/2004WO2004022780A2 Method for identifying substances having a herbicide action
03/18/2004WO2004022777A1 METHODS USING dsDNA TO MEDIATE RNA INTERFERENCE (RNAi)
03/18/2004WO2004022776A2 Gtp cyclohydrolase ii as a target for fungicides
03/18/2004WO2004022771A2 Short interfering nucleic acid hybrids and methods thereof
03/18/2004WO2004022765A2 Method for hydrolysing carotenoids esters
03/18/2004WO2004022764A2 Use of malate dehydrogenase for nadh regeneration
03/18/2004WO2004022763A1 Methods and means for improving retroviral integration
03/18/2004WO2004022762A1 Orthopoxvirus vectors, genes and products thereof
03/18/2004WO2004022761A1 Retroviral vector and stable packaging cell lines
03/18/2004WO2004022760A1 Generation of recombinant influenza virus using baculovirus delivery vector
03/18/2004WO2004022759A2 Method for improving corn starch extractability
03/18/2004WO2004022758A1 Genome partitioning
03/18/2004WO2004022756A2 Protein kinases
03/18/2004WO2004022755A2 Polypeptides involved in the regulation of flowering in forage grasses
03/18/2004WO2004022754A1 CONSTRUCTION OF ANTIBODY USING MRL/lpr MOUSE
03/18/2004WO2004022753A1 Novel actin-associated cytosekelton protein lacs
03/18/2004WO2004022752A1 Smg-1-binding protein and method of screening substance controlling its activity
03/18/2004WO2004022751A1 Cnidarian cytotoxin gene and its expression and application
03/18/2004WO2004022750A1 Novel diagnostic and therapeutic methods and reagents therefor
03/18/2004WO2004022749A1 Decoy-oligonucleotide-inhbition of cd40-expression
03/18/2004WO2004022748A1 Methods for gene silencing in transgenic animals
03/18/2004WO2004022747A1 Rational directed protein evolution using two-dimensional rational mutagenesis scanning
03/18/2004WO2004022746A1 In vitro peptide expression libraray
03/18/2004WO2004022745A2 Reversible, parallel and multitask cloning method and kit
03/18/2004WO2004022741A1 Artificial mammalian chromosome
03/18/2004WO2004022740A1 Satellite rnas and method of controlling cucumber mosaic virus using the same
03/18/2004WO2004022739A1 Antibody against n-terminal peptide or c-terminal peptide of gpc3 solubilized in blood
03/18/2004WO2004022738A1 Methods and compositions for the generation of humanized mice
03/18/2004WO2004022735A1 Method for producing a plant with a high-growth rate
03/18/2004WO2004022731A1 Process for producing virus vector containing membrane protein having sialic acid-binding activitiy in envelope with the use of gram-positive bacterium-origin neuraminidase
03/18/2004WO2004022729A1 Method for the cultivation of primary cells and for the amplification of viruses under serum free conditions
03/18/2004WO2004022726A1 Method of controlling biotic function through mechanical vibration and device therefor
03/18/2004WO2004022722A2 Lentiviral vectors, related reagents, and methods of use thereof
03/18/2004WO2004022721A2 Quantification of gene expression
03/18/2004WO2004022716A2 Recombinatant mutants of rhabdovirus and methods of use thereof
03/18/2004WO2004022715A2 Cloning and characterization of the broad-spectrum resistance gene pi2
03/18/2004WO2004022709A2 Epitope sequences
03/18/2004WO2004022708A2 Genes and proteins altering tau-related neurodegeneration
03/18/2004WO2004022702A2 Methods and reagents for identifying inhibitors of viral protease activity.
03/18/2004WO2004022701A2 Exponential amplification of nucleic acids using nicking agents
03/18/2004WO2004022700A2 Antifreeze proteins isolated from forage grasses and methods for their use
03/18/2004WO2004022697A2 Denaturat stable and/or protease resistant, chaperone-like oligomeric proteins, polynucleotides encoding same, their uses and methods of increasing a specific activity thereof
03/18/2004WO2004022683A1 A microbial oxidoreductase
03/18/2004WO2004022598A1 Fused protein with the function of both hemolysis and anticoagulation and the use of it
03/18/2004WO2004022597A1 Antibody against blood-solubilized n-terminal peptide in gpc3
03/18/2004WO2004022595A1 CONSTRUCTION OF ANTIBODY USING MRL/lpr MOUSE
03/18/2004WO2004022594A2 Immune modulatory compounds and methods
03/18/2004WO2004022593A2 Rational evolution of cytokines for higher stability, the cytokines and encoding nucleic acid molecules
03/18/2004WO2004022591A1 Akap18 delta, a novel splicing variant of a protein kinase a anchor protein and the use of the same
03/18/2004WO2004022589A1 Tumor tag and the use thereof
03/18/2004WO2004022588A1 Variants of the major allergen phl p 1 from timothy grass
03/18/2004WO2004022587A2 A pair of polypeptides with specific and strong interaction
03/18/2004WO2004022586A2 Tubulysin biosynthesis gene
03/18/2004WO2004022575A2 Bioinformatics analysis of cellular effects of artificial transcription factors